ORNL is a leader both in developing advanced radiotherapies and in providing the radioisotopes needed for those therapies.

To produce actinium-227, the isotope used for an FDA-approved cancer treatment, the first step is to bombard targets of the ...

This illustration shows targeted alpha therapy, in which actinium-225 is linked to a targeting molecule that binds to a ...

According to the World Nuclear Association, over 10,000 hospitals worldwide use radioisotopes in medicine1 with reports estimating that the nuclear radioisotope market will grow annually from $7 ...

More than one third of the nuclear reactors in operation around the world are used for research, educational purposes and the production of radioisotopes, rather than for power generation. Unlike ...